Juventas Therapeutics, Inc. announced that it has signed an investment agreement to receive $10,000,000 in funding on September 5, 2016. New investor, Merchavia Holdings and Investments Ltd. (TASE:MRHL) will invest $500,000 for 0.65% stake in the company. As part of the round, the investors will acquire 13% stake in the company.